Literature DB >> 19879325

Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression.

Ming He1, Lin Zhang, Ying Shao, Hong Xue, Li Zhou, Xiao-Fang Wang, Chen Yu, Tai Yao, Li-Min Lu.   

Abstract

Activation of prorenin/renin receptor [(P)RR] mediates non-enzymatic pathway for the physiological function of prorenin/renin. It also plays a role in the pathogenesis of diabetic nephropathy. However, the mechanisms of regulating (P)RR expression are only partially understood. In the present study, we examine the change of (P)RR under hyperglycemic conditions in the kidneys of streptozotocin (STZ)-induced diabetic (DM) rats and cultured rat renal glomerular mesangial cells (MCs). The (P)RR mRNA level was significantly lower in the kidney of (DM) rats than that of untreated control animals, meanwhile the plasma and renal angiotensin II (Ang II) levels and Ang II type 2 receptor (AT(2)R) mRNA level, but not Ang II type 1 receptor (AT(1)R) mRNA level were increased in (DM) rats. In cultured MCs, Ang II reduced the (P)RR expression and this inhibitory effect was blocked by the AT(2)R antagonist, PD123319, but not the AT(1)R antagonist, losartan. The AT(2)R agonist CGP42112A produced a similar effect as Ang II. Exposure to high glucose (30mM) resulted in a decrease in the (P)RR expression. PD123319, but not losartan, reversed high glucose induced (P)RR expression reduction. The present results indicate that activation of AT(2)R, but not AT(1)R, is most likely responsible for the reduced (P)RR expression in response to Ang II and high glucose in glomerular MCs and the renal tissue of STZ-treated rats. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879325     DOI: 10.1016/j.mce.2009.10.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

1.  Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy.

Authors:  Ze-Bo Hu; Kun-Ling Ma; Yang Zhang; Gui-Hua Wang; Liang Liu; Jian Lu; Pei-Pei Chen; Chen-Chen Lu; Bi-Cheng Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

Review 2.  Key developments in renin-angiotensin-aldosterone system inhibition.

Authors:  Bruno Sevá Pessôa; Nils van der Lubbe; Koen Verdonk; Anton J M Roks; Ewout J Hoorn; A H Jan Danser
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

3.  Activation of Cold-Sensitive Channels TRPM8 and TRPA1 Inhibits the Proliferative Airway Smooth Muscle Cell Phenotype.

Authors:  Lin Zhang; Xiaofei An; Qiuyu Wang; Ming He
Journal:  Lung       Date:  2016-05-28       Impact factor: 2.584

4.  SND p102 promotes extracellular matrix accumulation and cell proliferation in rat glomerular mesangial cells via the AT1R/ERK/Smad3 pathway.

Authors:  Jin-Lan Xu; Xin-Xin Gan; Jun Ni; De-Cui Shao; Yang Shen; Nai-Jun Miao; Dan Xu; Li Zhou; Wei Zhang; Li-Min Lu
Journal:  Acta Pharmacol Sin       Date:  2018-05-10       Impact factor: 6.150

5.  P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells.

Authors:  Jun Ni; Yang Shen; Zhen Wang; De-cui Shao; Jia Liu; Ya-li Kong; Lan-jun Fu; Li Zhou; Hong Xue; Yu Huang; Wei Zhang; Chen Yu; Li-min Lu
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

6.  Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney.

Authors:  Jun Ni; Yang Shen; Zhen Wang; De-cui Shao; Jia Liu; Lan-jun Fu; Ya-li Kong; Li Zhou; Hong Xue; Yu Huang; Wei Zhang; Chen Yu; Li-min Lu
Journal:  Acta Pharmacol Sin       Date:  2014-06-30       Impact factor: 6.150

7.  The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells.

Authors:  Cristina Balia; Valentina Scalise; Silvana Cianchetti; Francesca Faita; Tommaso Neri; Vittoria Carnicelli; Riccardo Zucchi; Alessandro Celi; Roberto Pedrinelli
Journal:  J Inflamm (Lond)       Date:  2016-05-04       Impact factor: 4.981

Review 8.  Sex Difference in MasR Expression and Functions in the Renal System.

Authors:  Samira Choopani; Mehdi Nematbakhsh
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2022-09-10       Impact factor: 4.109

9.  Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy.

Authors:  Lin Zhang; Xiao-Fei An; Xin Ruan; Dong-Dong Huang; Li Zhou; Hong Xue; Li-Min Lu; Ming He
Journal:  Front Physiol       Date:  2017-10-06       Impact factor: 4.566

10.  Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy.

Authors:  Ye-Ping Ma; Yue Yang; Shi-Min Jiang; Lin Liu; Zheng Zhang; Yi-Ning Wang; Gu-Ming Zou; Wen-Ge Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Apr-Jun       Impact factor: 1.636

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.